Clinical Trials Browser

Has results × pertuzumab × Genitourinary × Clear all

NCT02091141 2024-07-23

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

Phase 2 Completed

673 enrolled 22 charts

GastrointestinalGenitourinary

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Neoplasms

NCT02480010 2015-09-18

A Study of Pertuzumab in Participants With Prostate Cancer

Phase 2 Terminated

68 enrolled 18 charts

Prostatic Neoplasms

NCT00058539 2015-06-23

Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer

Phase 2 Completed

42 enrolled 10 charts

Prostatic Neoplasms